I Cornelissen Selected Research

I Cornelissen Research Topics

2	Atherosclerosis 08/2009 - 01/2001
2	Hemorrhage 01/2003 - 02/2001
2	Acute Lung Injury 01/2001 - 09/2000
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2001 - 09/2000
1	Atherosclerotic Plaque (Atheroma) 08/2009
1	Thrombosis (Thrombus) 08/2004
1	Pulmonary Embolism 08/2004
1	Disease Susceptibility (Diathesis) 01/2003
1	Fibrosis (Cirrhosis) 02/2001
1	Neointima 01/2001
1	Carcinoma (Carcinomatosis) 01/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2001
1	Inflammation (Inflammations) 01/2001
1	Lymphoma (Lymphomas) 01/2001
1	Vascular System Injuries 01/2001
1	Protein C Deficiency 04/2000

3	FibrinIBA 02/2001 - 01/2001
2	Thrombin FDA Link 08/2009 - 08/2004
2	CollagenIBA 01/2001 - 01/2001
2	Fibrinogen (Factor I)FDA Link 01/2001 - 01/2001
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2001 - 09/2000
1	Apolipoproteins E (ApoE)IBA 08/2009
1	ApolipoproteinsIBA 08/2009
1	protease-activated receptor 4IBA 08/2004
1	Thromboplastin (Tissue Factor)IBA 08/2004
1	Hemostatics (Antihemorrhagics)IBA 08/2004
1	Proteinase-Activated ReceptorsIBA 08/2004
1	Factor X (Stuart Factor)IBA 01/2003
1	Antineoplastic Agents (Antineoplastics)IBA 01/2001
1	CopperIBA 01/2001
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2001
1	SolutionsIBA 01/2001
1	Factor VII (Proconvertin)IBA 04/2000

1	Transplantation 01/2003